Pharmacokinetic, Efficacy, and Safety Study of Octafibrin Compared to Haemocomplettan/Riastap

NCT01575756 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Congenital Fibrinogen Deficiency
Afibrinogenemia

Interventions

BIOLOGICAL: Octafibrin
BIOLOGICAL: Haemocomplettan® P or RiaSTAPTM

Sponsor

Octapharma